Liang He

Department of Urology, First Hospital of Jilin University

Liang He, MD, PhD, is an attending urologist in the Department of Urology at the First Hospital of Jilin University, China. He received his MD and PhD degrees from Jilin University and completed joint doctoral training at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. He later conducted postdoctoral research at Karolinska Institutet, focusing on tumor biology and translational medicine. His work centers on urologic oncology and nanomedicine, with an emphasis on multifunctional nanomaterials, image-guided therapy, and regulated cell death–based mechanisms, integrating fundamental mechanistic studies with translational research to advance precision therapeutic strategies for urologic malignancies.

Yan Jiao

Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jilin University

Yan Jiao, MD, PhD, is an attending physician in the Department of Hepatobiliary and Pancreatic Surgery at the First Hospital of Jilin University, China. He obtained his PhD from Jilin University and specializes in hepatobiliary and pancreatic diseases, with a strong focus on translational and data-driven clinical research. Dr. Jiao has extensive expertise in bioinformatics and large-scale public database mining, including NHANES, FAERS, and TCGA, applying advanced statistical and computational methods to investigate disease mechanisms, drug safety, and clinical outcomes. He has authored over 70 peer-reviewed publications spanning gastroenterology, oncology, surgery, and computational medicine, and actively contributes to methodological rigor and research integrity in biomedical science.

Chao Zheng

Department of Neurology, First Hospital of Jilin University

Dr. Chao Zheng, MD, PhD, is a neurologist and physician at the First Hospital of Jilin University, China. She obtained her PhD from the Karolinska Institutet, where she conducted research in neuroimmunology and glial biology. Dr. Zheng’s research focuses on neuroimmune diseases, with particular emphasis on multiple sclerosis. Her work centers on oligodendrocyte biology, neuroinflammatory mechanisms, and immune–glia interactions, integrating fundamental mechanistic studies with translational research to advance therapeutic strategies for immune-mediated neurological disorders.

Shenglin Chen

Department of Hepatobiliary Surgery, Wuhu Hospital Affiliated to East China Normal University

Shenglin Chen, MD, MSc, is an associate chief physician and a member of the Youth Committee of the Wuhu Surgical Society as well as the Hepatobiliary and Pancreatic Surgery Committee of the Anhui Geriatrics Society. He received his master’s degree in surgery from Nanjing Medical University in 2014 and has since been engaged in clinical practice, teaching, and research in general surgery. In 2023, he completed advanced training at the First Affiliated Hospital of Guangzhou Medical University, focusing on percutaneous transhepatic one-stage biliary drainage and stone extraction for intrahepatic and extrahepatic bile duct stones. Dr. Chen has published multiple first-author papers in Scientific Reports, PLOS ONE, and the Journal of Surgical Research. His clinical expertise includes minimally invasive surgery for hepatobiliary–pancreatic, gastrointestinal, thyroid, hernia, and venous diseases.